GSMA
25.2.2020 13:02:04 CET | Business Wire | Press release
The GSMA today announced winners of the 2020 Global Mobile (GLOMO) Awards. The GLOMOs showcase those companies and individuals that are driving innovation in the rapidly evolving mobile industry.
“Our congratulations to all of the winners and nominees of the GSMA’s GLOMO Awards 2020,” said John Hoffman, CEO, GSMA Ltd. “The GLOMOs are a testament to the incredible innovation and ingenuity shaping our industry and it is truly an outstanding achievement to have been selected by our esteemed judging panels. We thank all of our entrants, judges, sponsors and partners for supporting the 2020 GLOMOs.”
The winners of the 2020 GLOMO Awards are:
Best Mobile Network Infrastructure
Vodafone, Parallel Wireless and Telecom Infra Project for Global OpenRAN Deployments
Best Mobile Technology Breakthrough (Companies > $10million Annual Global Revenue)
Ericsson for Ericsson Spectrum Sharing (ESS)
Best Mobile Technology Breakthrough (Companies < $10million Annual Global Revenue)
KaiOS for KaiOS, Enable Tomorrow
Best Network Software Breakthrough (Companies > $10million Annual Global Revenue)
Parallel Wireless for OpenRAN Controller and Network Software
Best Network Software Breakthrough (Companies < $10million Annual Global Revenue)
Cohere Technologies for Improved 4G and 5G FDD/TDD Networks
Best Mobile Authentication & Security Solution
Nuance Communications Inc. for Nuance Gatekeeper
5G Leadership Award
Huawei for Gear up with Huawei’s E2E 5G Products
5G Industry Partnership Award
China Unicom, BMW & Huawei for 5G Digital Factory Enable Automobile Manufacturing Digital Transformation
Outstanding Mobile Technology Award
Ericsson for Ericsson Spectrum Sharing (ESS)
Best Mobile Operator Service for Consumers
Vimplecom for Beeline & Liza Alert
Best Mobile service for the Connected Life
CalAmp for Here Comes The Bus
Most Innovative Mobile App
Turkcell for BiP Translate
Best Mobile Innovation for Work
China Eastern Airlines, China Unicom & Huawei for 5G Smart Travel in Airport
Best Mobile Innovation for Health and Biotech
Flare for World-Class Emergency Response Technologies
Best Mobile Innovation for Automotive
SK Telecom for Smart Fleet: Data Analytics Platform for Intelligent Mobility
Best Mobile Innovation for Payment and FinTech
Juvo for Financial Identity as a Service (FiDaaS)
Best Mobile Innovation for Smart Cities
China Mobile Group Zhejiang and Huawei for NB-IoT Smart City Fire Control
Best Mobile Innovation for Media and Entertainment
LG Uplus for U+VR 5G
Best Mobile Innovation for Building Trust in the Digital Age
Samsung Electronics for Knox Security Platform
Tech of the Future Award
Huawei for Atlas 900 AI Cluster - The Pinnacle of AI Compute for Future Inclusion
Best Smartphone
OnePlus for OnePlus 7T Pro
Disruptive Device Innovation Award
Qualcomm for Qualcomm Snapdragon X55 5G modem
Best Connected Consumer Device
Vasco Electronics for Vasco Mini2
Best Mobile Innovation for Emerging Markets
Safaricom for DigiFarm
Best Mobile Innovation supporting Emergency or Humanitarian Situations
MapSwipe for Missing Maps
Best Mobile Innovation for Accessibility & Inclusion
SK Telecom for Driving Assistance Solution for Hearing-Impaired Taxi Driver
Best Mobile Innovation for Climate Action
Huawei for Huawei PowerStar™ Solution, 3-Level AI-Based Energy Saving solution
Best Mobile Initiative for Enhancing Children’s Lives
Accenture for SAATHI – Autism Therapy at your Fingertips
Outstanding Mobile Contribution to the UN SDGs
KT for Global Epidemic Prevention Platform
Government Leadership Award
The Government of the Kingdom of Saudi Arabia
Outstanding Contribution to the Mobile Industry
Safaricom
Women4Technology – Industry Leadership Award
Elena Sinel, Founder for Teens In AI
Diversity in Tech Award
Teens In AI for Teens In AI
25 Years of Connecting People Award
Dr Mike Short - A constant champion of the role of mobile technology for the enhancement of society
YoMo STEAM Activity for Children Award
SK Telecom for Happy Coding School for Adolescents with Special Needs
For further information on GLOMO Awards winners please visit https://www.globalmobileawards.com/
- ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators and nearly 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200225005494/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy8.6.2026 12:00:00 CEST | Press release
Shilpa Biocare Pvt Ltd, a Subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED) has entered a strategic equity partnership with Gate2Brain, S.L., a biotechnology company focused on CNS therapeutics. Shilpa becomes a strategic shareholder and CMC, manufacturing, and regulatory partner for G2B-002 — Gate2Brain's lead program targeting deadly pediatric brain cancers, DIPG and pGBM, both with Orphan Drug Designation from the US FDA and EMA. G2B-002 uses Gate2Brain's proprietary MiniAp4 peptide shuttle to deliver SN-38 across the blood-brain barrier, demonstrating up to 100-fold greater brain drug transport preclinically. First-in-human trials are anticipated by FY28. G2B-002 targets high-growth oncology markets — the glioblastoma market projected at USD 6.48B by 2035 (CAGR: 7.97%), pediatric brain tumors at USD 2.47B by 2031 (CAGR: 6.9%), and DIPG at USD 1.2B by 2035 (CAGR: 7.1%). Gate2Brain's MiniAp4 platform further extends potential across rare pediatric cancers and broader CNS cat
Haleon Invests in India to Deliver Better Everyday Health to Rural Communities8.6.2026 11:11:00 CEST | Press release
£175m for first Haleon manufacturing site in Madhya Pradesh, central IndiaFast-growing India key to Haleon reaching one billion more consumers by 2030India’s consumer health market to reach over £23bn by 20301Accelerated rural distribution to access 3 million outletsAffordable Sensodyne packs and investment to double ‘last-mile’ reach in rural areas Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building a new oral health manufacturing site in Madhya Pradesh, central India and accelerate distribution efforts in rural India to meet rising demand. The new site will also support supply for wider Asia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608753094/e
Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-18.6.2026 10:56:00 CEST | Press release
Oraglutide™ Once Weekly, Low Dose, Low side-effect, Oral GLP-1 Glucose and Insulin Response Over 6 days: Clinical Data Posted at World ADA Diabetes & Obesity Conference Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small capsule intestinally-released oral semaglutide, formulated using the proprietary Axcess™ delivery technology. KEY HIGHLIGHTS 6-day glucose control: A single 4 mg oral dose of Oraglutide™ produced a sustained fall in glucose. Measuring 14% at Day 6 (p=.046), the longest duration presented from a single oral GLP-1 dose in a human IVGTT study. 28% increase in insulin secretion: Relative to placebo, insulin percent AUC increased by 12% day 0, (p=0.02) & 28% Day 1 (p = 0.025). Novel intestinal depot effect: Blood levels of semaglutide were higher on Day 1 than dosing on Day 0, consistent with lipid associated depot effect in the int
Reply at VivaTech 2026: Making AI, Agents and Robotics Happen Across the Enterprise8.6.2026 10:00:00 CEST | Press release
Reply[EXM, STAR: REY] is taking part in VivaTech 2026, Europe's largest innovation and technology event, held from June 17 to 20 at Paris Expo Porte de Versailles. At the event, Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608667672/en/ At VivaTech 2026 Reply will showcase its latest innovations around AI for software engineering, AI-powered experiences, data and AI, and industrial AI. Industries are being reshaped by AI, autonomous agents, robotics and new digital experiences. From strategy to execution, Reply helps companies move beyond experimentation and innovative ideas into concrete business value. Visitors can meet Reply in Hall 7.1, booth 1G12, and explore how, through real use cases, scalable solutions and live demonstrations, the group makes innovation happen. This year, Reply'
Cardiolife Partners with Bhutan Ministry of Health to Strengthen Nationwide Cardiac Care8.6.2026 10:00:00 CEST | Press release
Cardiolife is proud to partner with the Ministry of Health of Bhutan to roll out its advanced AI-powered ECG diagnostics system nationwide. The collaboration will provide access to early ECG diagnosis and prevention, marking a major step forward in the country’s effort to strengthen heart health and preventive care. Bhutan has a population of just over 700,000 people and heart failure and other cardiac conditionsare among the leading causes of death. Following constructive meetings in Thimphu, His Excellency, the Health Minister, officially endorsed the national rollout of Cardiolife’s solution and expressed appreciation for Cardiolife’s commitment to advancing cardiac care through the provision of free software and ECG equipment in Bhutan. “We are grateful to the Cardiolife team for their commitment to improving heart health in Bhutan. With cardiovascular diseases on the rise, this collaboration marks an important milestone in our journey to strengthen early detection and prevention a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom